AbCellera Announces Presentation of Phase 1/2 Data for ABCL635 at TMS 2026 Annual Meeting
VANCOUVER, British Columbia — AbCellera (Nasdaq: ABCL) today announced an upcoming poster presentation of Phase 1/2 data on ABCL635 at The Menopause Society’s (TMS) 2026 Annual Meeting, to be held October 20 to 24 at the Hilton Bayfront in San Diego, California. Details on AbCellera’s poster presentation at TMS are as follows: Title: Safety, pharmacokinetics, […]
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
